|
WO2010003773A1
|
|
Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancer
|
|
WO2010003772A1
|
|
Method for predicting adverse response to erythropoietin in breast cancer treatment
|
|
WO2007092847A2
|
|
Solid phase synthesis of acridinium derivatives
|
|
US2009208945A1
|
|
Method for the Prediction of Adverse Drug Responses to Stains
|
|
US2009171052A1
|
|
Polyelectrolyte Monolayers and Multilayers for Optical Signal Transducers
|
|
WO2007014338A2
|
|
Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
|
|
US2010047778A1
|
|
Methylation Specific Primer Extension Assay for the Detection of Genomic Imprinting Disorders
|
|
CN101111607A
|
|
Highly orthogonal universal sequences for use in nucleic acid assays
|
|
NZ541063A
|
|
ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
|
|
US2005221390A1
|
|
High quantum yield acridinium compounds and their uses in improving assay sensitivity
|
|
US2006018792A1
|
|
Read-head for optical diagnostic device
|
|
US2005283274A1
|
|
Robot alignment system and method
|
|
US7222059B2
|
|
Electrophoretic trace simulator
|
|
US2004063147A1
|
|
Applications of acridinium compounds and derivatives in homogeneous assays
|
|
US7285425B2
|
|
Assay test system for regulating temperature
|
|
EP1147421A1
|
|
Method for diagnosing endometriosis
|
